Abstract
In recent years, precision medicine has increased public awareness, particularly since 2020, when the COVID-19 epidemic struck almost every country in the world. Saudi Arabia is one of the affected countries, and this public health issue has affected many aspects of the country, including some key decision making in political, economic, healthcare and other major sector. Saudi Arabia is a country with the largest oil export in the world, and controlling the second largest oil reserves and the fourth largest gas reserves in the world, all these significant advantages make it occupy an important position in international relations. However, these advantages have also been a problem in the national development in the Kingdom of Saudi Arabia. For example, the revenue of the nation is too dependent on oil, resulting in uneven industrial development. With the launch of Saudi Vision 2030, the government shows its ambition in non-oil sectors and the nation also shows high interest on healthcare sector, such as precision medicine. In order to analyse the investment feasibility in precision medicine related projects in Saudi Arabia, data from different directions, such as political, economic, social and technological factors have been analysed.
Publisher
Darcy & Roy Press Co. Ltd.
Reference14 articles.
1. FDA (2018). Precision Medicine (2018) [online]. Available at: https://www.fda.gov/medical-devices/in-vitro-diagnostics/precision-medicine [Accessed 5 September 2022]
2. Excutive Office of the President of the United States (2008). Priorities for personalized medicine [online]. Available at: https://www.whitehouse.gov/ostp/ [Accessed 5 September 2022]
3. Hodson, R. (2016). Precision medicine. Nature 537, S49. https://doi.org/10.1038/537S49a
4. EPFL IRGC (2018). The Economics of Precision Medicine. A Risk Governance Perspective. Lausanne: EPFL International Risk Governance Center. DOI: 10.5075/epfl-irgc-256776
5. Rubin, E. H., Allen, J. D., Nowak, J. A., & Bates, S. E. (2014). Developing precision medicine in a global world. Clinical cancer research, 20(6), 1419–1427. https://doi.org/10.1158/1078-0432.CCR-14-0091